期刊文献+

MK-1抗原和再生基因蛋白Ⅳ在胆囊良恶性病变组织中的表达及其临床意义 被引量:5

Expressive levels of MK-1 antigen and regenerating gene Ⅳ and its clinicopathological significance in the benign and malignant lesions of gallbladder
原文传递
导出
摘要 目的探讨胆囊良恶性病变组织中MK-1抗原(MK-1)和再生基因蛋白Ⅳ(RegⅣ)的表达水平及其临床病理意义。方法108例胆囊腺癌、46例癌旁组织、15例腺瘤性息肉和35例慢性胆囊炎手术切除标本常规制作石蜡包埋切片,MK-1和RegⅣ染色方法均为EnVision免疫组织化学方法。结果胆囊腺癌MK-1和RegⅣ表达阳性率均明显高于癌旁组织(X2MK-1=18.76,P〈0.01;χ2RegⅣ=9.92,P〈0.01)、腺瘤性息肉(χ2MK-1=9.49,P〈0.01;X2RegⅣ=8.59,P〈0.01)和慢性胆囊炎(χ2MK-1=24.11,P〈0.01;χ2RegⅣ=19.24,P〈0.01);MK-1和RegIV表达阳性的良性病例的胆囊上皮均呈中至重度不典型增生。高分化、无淋巴结转移、未侵犯周围组织的病例MK-1表达阳性率明显高于低分化、淋巴结转移和侵犯周围组织的病例(P〈0.05或P〈0.01);高分化腺癌、无淋巴结转移和未侵犯周围组织的病例RegIV表达阳性率明显低于低分化腺癌、淋巴结转移和侵犯周围组织病例(P〈0.05或P〈0.01)。经Kaplan—Meier生存分析发现MK-1表达阳性病例术后生存期明显高于阴性表达病例(P〈0.01),但RegⅣ表达阳性病例术后生存期明显低于阴性表达病例(P〈0.01);Cox多变量回归分析显示,MK-1阴性表达和(或)RegIV阳性表达可反映胆囊腺癌预后不良。结论MK-1和RegⅣ表达与胆囊腺癌发生、临床生物学行为及预后密切相关。 Objective To study the expression levels of MK-1 antigen and regenerating gene Ⅳ (RegⅣ) and their clinicopathologieal significance in the benign and malignant lesions of gallbladder. Methods EnVisionTM immunohistoehemical method for determining the expression of MK-1 and Reg Ⅳ was used in routinely paraffin-embedded sections of surgically reseeted specimens from gallbladder adeno- carcinoma ( n = 108 ), peritumoral tissues ( n = 46), adenomatous polyp ( n = 15 ), and chronic cholecysti- tis ( n = 35 ). Results The positive rate of MK-1 or RegⅣ expression was significantly higher in gallblad- 2 der adenocarcinoma than that in peritumoral tissues (XMK-I: 18.76,P〈0.01 ;XRosⅣ2 =9.92,P〈0.01), adenomatous polyp(XMK-12= 9.49, P 〈 0. 01 ;XResⅣ2 = 8.59, P 〈 0. 01 ) and chronic cholecystitis (χ2MK-12 = 24. 11 ,P 〈 0. 01;XRegⅣ2 = 19.24 ,P 〈 0. 01 ). The positive cases of MK-1 and/or Regiv in the benign le- sions showed moderate- or severe-atypical hyperplasia of gallbladder epithelia. The positive rate of MK-1 was significantly higher in the cases of well-differentiated adenocarcinoma, no-metastasis of lymph node, and no-invasiveness of regional tissues than that in the cases of low-differentiated adenocarcinoma, metasta- sis of lymph node, and invasiveness of regional tissues in gallbladder adenocarcinoma ( P 〈 0. 05 or P 〈 0. 01 ). The positive rate of Regiv was significantly lower in the eases of well-differentiated adenocarcinoma, no-metastasis of lymph node, and no-invasiveness of regional tissues than those in the cases of low-differentiated adenocarcinoma, metastasis of lymph node, and invasiveness of regional tissues in gallbladder adenocar- cinoma ( P 〈 0. 05 or P 〈 0. 01 ). Unitivariate Kaplan-Meier analysis revealed that the decreased expression of MK-1 (P 〈0. 01 ) or increased expression of RegIV (P 〈0. 01 ) was associated with decreased overall survival. Multivariate Cox regression analysis demonstrated that the decreased expression of MK-1 (P 〈 0.05 ) and/or increased expression of RegⅣ (P 〈 0. 01 ) was an independent bad-prognostic predictor in gallbladder adenocarcinoma. Conclusion The expression of MK-1 and/or RegiV might be closely related to the carcino- genesis, clinical biological behaviors, and prognosis of gallbladder adenocarcinoma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第9期1481-1484,共4页 Chinese Journal of Experimental Surgery
关键词 胆囊肿瘤 MK-1 再生基因蛋白Ⅳ Gallbladder neoplasms MK-1 Regenerating gene Ⅳ
  • 相关文献

参考文献16

  • 1Abe H, Kuroki M, Imakiive T, et al. Preparation of recombinant MK- 1/Ep-CAM and establishment of an ELISA system for determing solu- ble MK-1/Ep-CAM levels in sera of cancer. J Immunol Methods, 2002,27:227-233.
  • 2Deveci MS,Deveci G. Prognostic value of p53 protein and MK-1 (a tumor-associated antigen ) expression in gastric carcinoma. Gastric Cancer,2007, 10 : 112-116.
  • 3EI-Meghaw EI-kenawy A,EL-kott AF, Hamed SM,et al. Prognostic value of carcinoma-associated antigen MK-1 in urinary bladder carci- noma. Int J Biol Markers,2006,21:170-174.
  • 4Ikeda T,Nakayama Y, Hamada Y, et al. Fu-MK-1 expression in hu- man gallbladder carcinoma : an antigenic prediction marker for a bet- ter postsurgical prognosis. Am J Clin Pathol,2009,132 : 111-117.
  • 5Hamada Y, Nakayama Y, Mizoguchi M, et al. MK-1 expression in car- cinoma of the ampulla of rater as a predictor of improved prognosis af- ter surgical resection. Cancer Lett, 2006,243:211-216.
  • 6Yamagishi H, Fukui H, Sekikawa A, et al. Expression profile of REG family proteins Reg 1 alpha and ReglV in advanced gastric cancer: comparision with mucin phenotype and pregnostic markers. Mod Pathol,2009,22 : 906 -913.
  • 7Kuniyasu H, Oue N, Sasahlra T, et al. RegⅣ enhances peritoneal me- tastasis in gastric carcinomas. Cell Prolif,2009,42 : 110-121.
  • 8Bishnupuri KS, Luo Q, Korzenik JR, et al. Dysregulation of Reg gene expression occurs early in gastrointestinal tumorigenesis and regulates anti-apoptotic genes. Cancer Biol Ther,2006,5 : 1714-1720.
  • 9Pankova-kholmyansky I,Arber N. RegⅣ can serve for early diagnosis and therapy. Cancer Biol Ther,2007,6 : 123-124.
  • 10Hayashi T, Matsubara A, Ohara S, et al. Immunohistochemical analy- sis of Reg Ⅳ in urogenital organs: Frequent expression of Reg Ⅳ in prostate cancer and potential utility as serum tumor marker. Oncol Rep,2009,21:95-100.

二级参考文献9

  • 1Takai N, Miyazaki T, Nishida M, et al. Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Cancer Letters, 2002, 184 : 105-116.
  • 2Kim PJ, Plescia J, Clevers H, et al. Survivin and molecular pathogenesis of colorectal cancer. Lancet, 2003, 362: 205-209.
  • 3Adida C, Crotty PL, McGrath J, et al. Developmentally regulated expression of the novel cancer Anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol, 1998, 152:43-49.
  • 4Zhao J, Tenev T, Martins LM, et al. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci, 2000, 113:4363-4371.
  • 5Shin S, Sung BJ, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor of Caspase-3 and -7. Biochemistry, 2001,40:1117-1123.
  • 6Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin,expressed in cancer and lymphoma. Nat Med, 1997, 3 : 917-921.
  • 7Kami K, Doi R, Koizumi M, et al. Survivin expression is a prognostic marker in pancreatic cancer patients. Surg, 2004, 136:443-448.
  • 8Hui AM, Shi YZ, Li X, et al. Proliferative marker Ki-67 in gallbladder carcinomas:high expression level predicts early recurrence after surgical resection. Cancer Letters, 2002, 176 : 191-198.
  • 9石景森,杨毅军,赵凤林,王作仁,周连锁,王林,王健生,何平,卢云,孙立江,焦兴元,刘绍诰.原发性胆囊癌44年诊治的临床回顾[J].外科理论与实践,2001,6(3):137-141. 被引量:47

共引文献16

同被引文献19

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部